Q-omics provides the consensus-scored PRR20C profile across patient tissues and cancer cell-line models.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for PRR20C — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with PRR20C in patient tissues and cancer cell lines. In cancer cell lines, PRR20C RNA and mutation anchors are most strongly linked to RNA-expression features, especially in UPPER_AERODIGESTIVE_TRACT, while CRISPR and shRNA rows add functional-dependency signals in BLOOD_Myeloma.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	1,140	UPPER_AERODIGESTIVE_TRACT (396)	view →
shRNA	179	BLOOD_Myeloma (92)	view →